explore -WSS

explore

author：comprehensive 2025-09-03 03:27:36 - browse：773

Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit. — Priscilla Chan and Mark Zuckerberg appear virtually at the 2023 STAT Summit. STAT

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease.

The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. It joins the original San Francisco Biohub founded in 2016 and a Chicago Biohub founded earlier this year.

“About the five-year mark, we basically sat down and tried to assess what we thought was working well and what we want to double down on,” Zuckerberg told STAT. “And we thought that the Biohub model to bring a few universities together, coupling that with engineering and a long-term goal, was a model that was really doing well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： In 'major milestone,' FDA approves first cell therapy for solid tumors

WSS

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

New study raises questions about niacin and heart health

Medicare Advantage enrollment hits roughly 33.4 million

Researchers tackle phage therapy hurdles for wider adoption

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

explore

explore

focus

Peter Hotez and the public health issue of online harassment

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Walensky prepares to leave CDC — and Congress — behind

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Drug repurposing or repositioning? The language matters

Congress gives doctors Medicare pay bump

Medicare proposal to cover medical devices draws a mixed reaction

Scientists unlock the key to scar

Peter Hotez and the public health issue of online harassment

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

entertainment

Medicare Advantage enrollment grows 7.1% to 33.4 million people

New CMS data security rules will hurt Medicare, Medicaid research

International team creates first chimeric human

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

How to fix the rural physician shortage in the U.S.

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

hotspot

hotspot

leisure time

explore